Abstract
The authors regret that Israa Yousif EL Khidir's university and email address was wrong in the published version. The correct details are as follows: Israa Yousif EL Khidir, Department of Clinical Pharmacy, (PhD, MSc), Assistant Professor, College of Pharmacy, Najran University, Najran -King Saudi Arabia (KSA). Email: [email protected], which has been corrected as above. The details listed in this corrigendum are correct and compl/ete. The authors would like to apologise for any inconvenience caused.
| Original language | English |
|---|---|
| Article number | 102047 |
| Journal | Saudi Pharmaceutical Journal |
| Volume | 32 |
| Issue number | 5 |
| DOIs |
|
| State | Published - May 2024 |
UN SDGs
This output contributes to the following UN Sustainable Development Goals (SDGs)
-
SDG 3 Good Health and Well-being
Fingerprint
Dive into the research topics of 'Corrigendum to “A narrative review of approved and emerging anti-obesity medications” [Saudi Pharm. J. 31(10) (2023) 101757] (Saudi Pharmaceutical Journal (2023) 31(10), (S1319016423002529), (10.1016/j.jsps.2023.101757))'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver